Most lately, it's been determined that conolidine and the above derivatives act to the atypical chemokine receptor 3 (ACKR3. Expressed in very similar locations as classical opioid receptors, it binds to a big range of endogenous opioids. Unlike most opioid receptors, this receptor acts as a scavenger and would not activate a second messenger proce